Table 2.
List of photosensitisers under investigation for melanoma PDT (2018 to 2022).
| Study (Authors, Year) | Photosensitiser | Absorption Wavelength (nm) | Antibody | Nanoparticle |
|---|---|---|---|---|
| Tang et al., 2018 [165] | Indocyanine green (ICG) | 808 | None | Carboxylated poly (amido-amine) |
| Bazylińska et al., 2018 [166] | Chlorin e6 (Ce6) | 600–630 | None | Cubosomes |
| Bazylińska et al., 2018 [166] | Meso-tetraphenylporphine-Mn (III) chloride (TPP-Mn (III)cl) | 530–570 | None | Cubosomes |
| Clemente et al., 2019 [167] | Verteporfin (Ver) | 690 | None | Mesoporous silica nanoparticles (MSNs) |
| Lee et al., 2019 [168] | ICG | 785 | None | Chitosan-coated liposomes |
| Li et al., 2020 [169] | Pyropheophorbide a (Ppa) | 670 | None | Amphiphilic micelles |
| Li et al., 2020 [170] | Ce6 | 980 | None | Mesoporous coated upconverting nanoparticles |
| Naidoo et al., 2019 [103] | Zinc phthalocyanine tetra-sulphonic acid | 673 | Melanoma inhibitory activity antigen | Gold |
| Ghazaeian et al., 2021 [171] | Curcumin | 465 | None | Silica |
| Biteghe et al., 2020 [14] | Hypericin with doxorubicin | 561 | None | None |
| Zhang et al., 2019 [30] | 5-ALA with 5-FU and 5-MA pre-treatment | 633 ± 10 | None | None |